Vfend Special Investigation For Prophylaxis

Trial Profile

Vfend Special Investigation For Prophylaxis

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Aug 2017

At a glance

  • Drugs Voriconazole (Primary)
  • Indications Mycoses
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 23 Mar 2016 Status changed from not yet recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
    • 01 Mar 2016 Planned End Date changed from 1 Dec 2018 to 1 Jun 2019 as reported by ClinicalTrials.gov.
    • 01 Mar 2016 Planned primary completion date changed from 1 Dec 2018 to 1 Jun 2019 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top